Network-based drug repurposing for MYH9-related nephritis
Muhammad Ali (1), Tommaso Gili (2), Guido Caldarelli (3,1,4) ((1) DSMN Ca'Foscari, University of Venice, Italy, (2) Networks Unit, IMT Lucca, Italy, (3) Institute of Complex Systems, CNR-ISC, Rome Italy, (4) LIMS, Royal Institution, London UK)

TL;DR
This study applies network theory to analyze a drug-like compound library related to MYH9 nephritis, revealing significant modularity and structural organization useful for drug repurposing.
Contribution
It introduces a multi-descriptor network approach to characterize chemical space, identifying consensus compounds and structural backbones for drug discovery.
Findings
High modularity in chemical networks indicates nonrandom organization.
A sparse high-consensus core of compounds emerges across descriptors.
Distinct backbone topologies reveal different structural and consensus network properties.
Abstract
Using tools from network theory, we analyze the organization of a MYH9-oriented drug-like library in chemical space using a multi-descriptor framework. The dataset is drawn from ZINC, a publicly available database of commercially accessible compounds curated for virtual screening and drug discovery. Starting from 6004 molecules, preprocessing yields 5000 structurally valid and descriptor-complete compounds. Similarity is defined via Tanimoto distance on Morgan fingerprints and single-descriptor distances for xLogP, HBD, HBA, molecular weight, and rotatable bonds. For each representation, we construct k-nearest-neighbor networks and identify communities using the Louvain-Leiden algorithm. All networks exhibit highly significant modularity (Q=0.91-0.99) relative to degree-preserving null models, demonstrating pronounced nonrandom chemical organization across descriptors. Cross-descriptor…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsComputational Drug Discovery Methods · Molecular spectroscopy and chirality · Crystallography and molecular interactions
